ACE-I
Recently ACE-I have been       found to decrease plasma levels of circulating vascular cell adhesion molecule-1        (cVCAM-1) in patients with congestive heart failure.
Recently  @SUBJECT$  have been       found to  @PREDICAT$  plasma levels of circulating  @OBJECT$         (cVCAM-1) in patients with congestive heart failure.